Highest Revenue
checkbookThese companies stand out for their exceptional revenue generation and represent the industry's top performers.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardRevenue | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AUUD AUUDWAuddia | $0.03 | $0.00 | arrow_drop_up26.10% | $15.47K | 9.61K | 0.03 | _ | Neutralremove | - | -37.40% | |||||
BEATWHeartBeam | $0.53 | $0.53 | 0.00% | $15.13M | 1.81K | 0.53 | _ | Neutralremove | - | 5.68% | |||||
BAOS BAOSBaosheng Media Group Holdings Limited Ordinary shares | $2.34 | $0.02 | arrow_drop_up0.84% | $3.68M | 29.22K | 2.41 | _ | Neutralremove | - | -31.02% | |||||
 BFHBread Financial Holdings | $50.53 | -$0.52 | arrow_drop_down1.01% | $2.52B | 257.87K | 50.49 | _ | Neutralremove | 1.56% | 21.32% | |||||
ENVBEnveric Biosciences | $1.27 | $0.06 | arrow_drop_up4.95% | $3.11M | 94.55K | 1.23 | _ | Neutralremove | - | -89.79% | |||||
CNSPCNS Pharmaceuticals | $1.08 | -$0.06 | arrow_drop_down5.24% | $4.11M | 151.26K | 1.11 | _ | Neutralremove | - | -99.79% | |||||
ALZNAlzamend Neuro | $3.58 | $0.02 | arrow_drop_up0.56% | $2.41M | 32.58K | 3.58 | _ | Neutralremove | - | -93.58% | |||||
FTFTFuture FinTech Group | $1.54 | -$0.07 | arrow_drop_down4.45% | $4.39M | 61.45K | 1.55 | _ | Neutralremove | - | -81.44% | |||||
REALRealReal | $5.23 | $0.01 | arrow_drop_up0.28% | $596.01M | 1.48M | 5.22 | _ | Neutralremove | - | 28.62% | |||||
TBMC TBMCTrailblazer Merger Corporation I - Class A Common Stock | $11.94 | $0.04 | arrow_drop_up0.33% | $53.40M | 101.35K | 11.86 | _ | Neutralremove | - | 10.69% | |||||
KEKimball Electronics | $17.40 | -$0.18 | arrow_drop_down1.02% | $441.52M | 119.83K | 17.48 | _ | Neutralremove | - | -23.05% | |||||
BONBon Natural Life Limited | $1.87 | -$0.23 | arrow_drop_down10.95% | $195.75K | 2.03M | 1.92 | _ | Neutralremove | - | -97.59% | |||||
ROCLWRoth Ch Acquisition V Co. | $0.40 | $0.16 | arrow_drop_up68.35% | $0.00 | 350.76K | 0.42 | _ | Neutralremove | - | 344.44% | |||||
GLMDGalmed Pharmaceuticals Ltd | $1.37 | -$0.04 | arrow_drop_down2.83% | $2.84M | 98.44K | 1.37 | _ | Neutralremove | - | -71.19% | |||||
OCTOEightco Holdings | $1.24 | -$0.03 | arrow_drop_down2.36% | $4.30M | 7.08K | 1.26 | _ | Neutralremove | - | -62.88% | |||||
INMInMed Pharmaceuticals | $2.71 | $0.11 | arrow_drop_up4.00% | $3.55M | 39.59K | 2.79 | _ | Neutralremove | - | -61.53% | |||||
XRTXXORTX Therapeutics | $0.97 | -$0.02 | arrow_drop_down2.40% | $3.56M | 863.00 | 0.98 | _ | Neutralremove | - | -62.60% | |||||
MMATMeta Materials | $0.37 | -$0.02 | arrow_drop_down5.11% | $3.52M | 27.46K | 19.23K | _ | Neutralremove | - | -87.90% | |||||
TTOOT2 Biosystems | $0.13 | -$0.06 | arrow_drop_down34.61% | $3.50M | 15.08M | 0.13 | _ | Neutralremove | - | -97.61% | |||||
CSSEChicken Soup For The Soul Entertainment | $0.00 | $0.00 | arrow_drop_up13.09% | $3.42M | 7.66K | 84.77K | _ | Buykeyboard_arrow_up | - | -96.99% |
Showing 3621-3640 of 4978
Results per page:
About Highest Revenue
Enter the realm of stocks with the highest revenue, where companies are crushing their sales targets and achieving remarkable financial success. Revenue is a critical metric that measures a company's top-line performance, reflecting its ability to generate substantial income from its products or services.
Investors seeking promising opportunities often look to stocks with impressive revenue figures, as it indicates the company's market strength and demand for its offerings. These high revenue stocks can be attractive options for long-term investors seeking stable and prosperous ventures.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools